deus semaglutide Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity FBI issues safety warning about

The clinical trials that established semaglutide's efficacy and safety profileincluding the SUSTAIN trials for diabetes and the STEP trials for weight managementall utilized weekly dosing schedules

I hired a personal trainer, and she came to my house

As part of its long-term sustainability commitment, Ypsomed has joined the Science Based Targets initiative (SBTi), targeting net zero emissions across its entire value chain by 2040

Does Hawaii's Healthcare System Support Compounded Semaglutide Access

Superior Weight Loss With Once-Weekly Semaglutide Versus Other Glucagon-Like Peptide-1 Receptor Agonists is Independent of Gastrointestinal Adverse Events